logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 


Covidien (COV) Paying $680 Million for Camera-in-a-Pill Maker Given Imaging (GIVN)

By  +Follow December 9, 2013 7:38AM
Share:
Tickers Mentioned:

Medical device manufacturer Covidien plc (COV) said Sunday that it is buying medical technology company Given Imaging Ltd. (GIVN) in a transaction valued at $860 million to expand its gastrointestinal diagnostic business. The news came after three units of Nochi Dankner’s IDB group agreed Saturday to sell their positions in Given Imaging, although the name of the buyer was not disclosed.

Covidien, which is headquartered in Dublin, Ireland, said it will pay $30 per share for Israel-based Given, representing about a 27-percent premium to Friday’s closing price of $23.65 per share of GIVN. The boards of both companies have approved the acquisition, which is expected to close by the end of March 2014.

Capsule Endoscopy

Given Imaging is a pioneer in capsule endoscopy. The company has developed PillCam, an ingestible capsule containing a tiny camera that when swallowed allows clinicians to look inside, and monitor and diagnose the digestive system as an alternative to a traditional endoscopy. Given has been under pressure for nearly two years to sell itself, including investor Discovery Group urging the company in October to initiate a $50 million share buy-back plan and put itself on the auction block again, saying it is chronically undervalued because of poor management. At that time, Discovery Group, which owns about 4 percent of Given Imaging, thought the company could get an offer of up to $30 per share. Looks like it was right.

Covidien said that it will use cash on hand to fund the purchase. Given Imaging will report within the medical devices segment of Covidien and is expected to add between $40 million to $50 million per quarter in incremental revenue to the division. From profit and operating margin standpoints, the acquisition is not expected to be accretive until fiscal 2015.

A Strong Q3 for Given Imaging

During the third quarter ended September 30, Given Imaging generated $50 million in sales, up 10 percent from the year prior quarter. Adjusted earnings were $8.2 million, or 25 cents per share, up 4 percent from Q3 2012. Global PillCam sales increased 9 percent during the quarter to 63,500 capsules. Worldwide sales of GI diagnostics products improved by 15 percent to $15.3 million. By integrating the Given Imaging operations, Covidien will be able to leverage its global reach to further bolster sales of Given’s products.

“We believe GI is one of the most attractive specialty procedure areas. Acquiring Given will enable Covidien to significantly expand its presence in a $3 billion GI market,” said Bryan Hanson, Group President, Medical Devices & U.S., Covidien, in a statement today.

“After thoroughly evaluating our strategic options we determined that this transaction is in the best interests of Given Imaging, its shareholders and employees and provides unique benefits to patients globally,” added Homi Shamir, president and chief executive at Given Imaging Ltd.

Shares of GIVN jumped ahead to near the buyout price at the opening bell. Through Friday’s close, the stock price was up about 33 percent in 2013. Shares of COV, which were up 28 percent in 2013 through Friday, have inched up about half a percent in Monday morning action to $68.48.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for COV
SmallCaps
31 Mar 15 23:12:25
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
$COP
31 Mar 15 17:03:08
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/jmlApw49Hx … … … …… http://t.co/ar5rXoWptA
$COP
31 Mar 15 16:49:32
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/jmlApw49Hx … … … …… http://t.co/ar5rXoWptA
$COP
31 Mar 15 16:30:47
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/jmlApw49Hx … … … …… http://t.co/ar5rXoWptA
$COP
31 Mar 15 16:14:43
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/jmlApw49Hx … … … … http://t.co/ar5rXoWptA
$COP
31 Mar 15 15:59:46
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/jmlApw49Hx … … … http://t.co/ar5rXoWptA
$COP
31 Mar 15 15:43:26
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/jmlApw49Hx … … http://t.co/ar5rXoWptA
$COP
31 Mar 15 15:27:31
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/jmlApw49Hx … http://t.co/ar5rXoWptA
$COP
31 Mar 15 15:11:29
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/jmlApw49Hx http://t.co/ar5rXoWptA
Analyst Ratings
31 Mar 15 14:57:50
Want automatic email alerts for $COP $COV $TRW $ABC $ALGT? Subscribe to ARN Daily http://t.co/nSJuDsYidj
Harry Walkman
31 Mar 15 14:33:22
$COV Medtronic finalizes $42.9b Covidien deal http://t.co/N49yTXMMhh
SmallCaps
31 Mar 15 09:52:14
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
SmallCaps
30 Mar 15 20:30:51
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
Hill Capital Mgt
30 Mar 15 15:46:05
RT @HedgeMind: RT "10 biotechs w/ most high conviction buyers: $AGN $COV $ACT $GILD $LH $CBST $CFN $VRX $SLXP $HZNP Find out http://t.co/dt…
HedgeMind
30 Mar 15 11:34:57
RT "10 biotechs w/ most high conviction buyers: $AGN $COV $ACT $GILD $LH $CBST $CFN $VRX $SLXP $HZNP Find out http://t.co/dtRGWM6DtS"
SmallCaps
30 Mar 15 04:22:00
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
Penny Stock Secret
30 Mar 15 00:46:28
This Guy Is Making Millions! Watch This Video Proof Here At http://t.co/NovWYe2RAx .. $COV $CP $CPA
PennyStock Zone
29 Mar 15 22:30:22
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/HMYdF92FUf $RFMD $IYT $MERC $GASL $COV $RH
Vincent Menard
29 Mar 15 18:33:19
On the weekly TSX/TSV healthcare wrap-up : DOWN - $COV, $TLB, $VVA / UP - $NHC, $NDQ, $IM.
SmallCaps
29 Mar 15 15:00:55
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
SmallCaps
29 Mar 15 10:39:48
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
SmallCaps
29 Mar 15 05:55:26
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
PennyStock Zone
28 Mar 15 15:48:17
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/HMYdF92FUf $RFMD $IYT $MERC $GASL $COV $RH
SmallCaps
28 Mar 15 00:22:40
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
SmallCaps
27 Mar 15 20:06:30
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
4-traders.com
27 Mar 15 14:03:26
#Covalon Technologies : Announces Issuance of Stock Options http://t.co/FJqfRMpWGz $COV
Daily Contracts
27 Mar 15 12:27:11
Real-Time feed of company contracts, original agreements and executive updates from $COV http://t.co/7sENsarx1h
SmallCaps
27 Mar 15 11:14:25
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
Peter Bardens
27 Mar 15 09:06:25
$COV Medtronic finalizes $42.9b Covidien deal http://t.co/27iGaZxaC8
SmallCaps
27 Mar 15 05:51:08
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
SmallCaps
26 Mar 15 23:07:22
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
PennyStock Zone
26 Mar 15 19:17:06
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/HMYdF92FUf $RFMD $IYT $MERC $GASL $COV $RH
Cole Lannum
26 Mar 15 17:05:07
So, for the first award of the night, we (Covidien) are up against Medtronic. #Irony #IRawards $MDT $COV
medtech[y]
26 Mar 15 10:35:02
Another great article from @MassDevice on the future of the rep-less sales model. Join the discussion.| http://t.co/szvFM2f5lQ $SNN $COV
SmallCaps
26 Mar 15 06:48:34
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqurh3 $RFMD $IYT $MERC $GASL $COV $RH
Samuel Brown
26 Mar 15 06:36:13
$COV Medtronic to Buy Device Maker Covidien for $42.9 Billion http://t.co/DccwGqANTc
Jeffrey Blake
26 Mar 15 06:36:07
$COV Medtronic finalizes $42.9b Covidien deal http://t.co/byvBBGC3aQ
Peter Bardens
26 Mar 15 05:02:47
$COV Medtronic to Buy Device Maker Covidien for $42.9 Billion http://t.co/rMBdavleZd
John Turner
26 Mar 15 05:02:45
$COV Medtronic finalizes $42.9b Covidien deal http://t.co/BYZh9gyFLx
SmallCaps
25 Mar 15 13:02:33
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
SmallCaps
25 Mar 15 07:53:27
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/AKjszqM28B $RFMD $IYT $MERC $GASL $COV $RH
PennyStock Zone
25 Mar 15 06:55:14
Review of Timothy Sykes book: An American Hedge Fund: http://t.co/HMYdF92FUf $RFMD $IYT $MERC $GASL $COV $RH
				
				
By  +Follow December 9, 2013 7:38AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.